1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors
- 15 October 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (20) , 4604-4610
- https://doi.org/10.1016/j.bmcl.2005.06.064
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseasesMicrobes and Infection, 2003
- Selective adenosine A2A receptor antagonistsIl Farmaco, 2001
- The Role and Regulation of Adenosine in the Central Nervous SystemAnnual Review of Neuroscience, 2001
- A Novel Class of Highly Potent and Selective A1 Adenosine Antagonists: Structure−Affinity Profile of a Series of 1,8-Naphthyridine DerivativesJournal of Medicinal Chemistry, 2000
- [3H]‐SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranesBritish Journal of Pharmacology, 1998
- Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal gangliaTrends in Neurosciences, 1997
- Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]‐SCH 58261 bindingBritish Journal of Pharmacology, 1997
- Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]‐CGS 21680 bindingBritish Journal of Pharmacology, 1996
- Adenosine Receptor Subtypes: Characterization and Therapeutic RegulationAnnual Review of Pharmacology and Toxicology, 1995
- Cardiovascular purinoceptorsPhysiological Reviews, 1990